Stomach cancer

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.

People who are overweight in their twenties and become obese later in life may be three times more likely to develop oesophageal or upper stomach cancer.

We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus.

The world’s largest ever clinical trial looking at whether taking aspirin stops some of the most common cancers coming back, launches across the UK today.

We explore new data showing that cancer survival in England remains lower than countries with similar healthcare systems.